January 30, 2019
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Read More
January 30, 2019
Low-dose Glucocorticoid Vasculitis Induction Study
Read More
January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)
Read More
January 30, 2019
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Study of SU011248 in Patients With Advanced Kidney Cancer
Read More
January 30, 2019
Study of SU011248 in Patients With Advanced Kidney Cancer
Read More
January 30, 2019
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
Read More
January 30, 2019
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
Read More
Load More
X